The oxidized phospholipid PGPC impairs endothelial function by promoting endothelial cell ferroptosis via FABP3
Journal of Lipid Research · 2024-02 · 65 (2) · 100499
DOI: 10.1016/j.jlr.2024.100499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2024-02. Verfasst von Si Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Cardiovascular Diseases Institute, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; National-Gua…. Hauptthemen laut MEDLINE: Ferroptosis, Atherosclerosis, Cyclohexylamines, Phenylenediamines. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sun Yat-sen University, National Key Research and Development Program of China, Science and Technology Planning Project of Fuzhou.
Abstract (Originalsprache)
Ferroptosis is a novel cell death mechanism that is mediated by iron-dependent lipid peroxidation. It may be involved in atherosclerosis development. Products of phospholipid oxidation play a key role in atherosclerosis. 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine (PGPC) is a phospholipid oxidation product present in atherosclerotic lesions. It remains unclear whether PGPC causes atherosclerosis by inducing endothelial cell ferroptosis. In this study, human umbilical vein endothelial cells (HUVECs) were treated with PGPC. Intracellular levels of ferrous iron, lipid peroxidation, superoxide anions (O2•-), and glutathione were detected, and expression of fatty acid binding protein-3 (FABP3), glutathione peroxidase 4 (GPX4), and CD36 were measured. Additionally, the mitochondrial membrane potential (MMP) was determined. Aortas from C57BL6 mice were isolated for vasodilation testing. Results showed that PGPC increased ferrous iron levels, the production of lipid peroxidation and O2•-, and FABP3 expression. However, PGPC inhibited the expression of GPX4 and glutathione production and destroyed normal MMP. These effects were also blocked by ferrostatin-1, an inhibitor of ferroptosis. FABP3 silencing significantly reversed the effect of PGPC. Furthermore, PGPC stimulated CD36 expression. Conversely, CD36 silencing reversed the effects of PGPC, including PGPC-induced FABP3 expression. Importantly, E06, a direct inhibitor of the oxidized 1-palmitoyl-2-arachidonoyl-phosphatidylcholine IgM natural antibody, inhibited the effects of PGPC. Finally, PGPC impaired endothelium-dependent vasodilation, ferrostatin-1 or FABP3 inhibitors inhibited this impairment. Our data demonstrate that PGPC impairs endothelial function by inducing endothelial cell ferroptosis through the CD36 receptor to increase FABP3 expression. Our findings provide new insights into the mechanisms of atherosclerosis and a therapeutic target for atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Cardiovascular Diseases Institute, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vas…
- National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, NHC Key Laboratory of Assisted Circulation and Vascular Diseases (Sun Yat-sen University), Key Laboratory of Assisted Cir…
- Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangzh…
Förderung
- Sun Yat-sen University
- National Key Research and Development Program of China
- Science and Technology Planning Project of Fuzhou
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Chen, S., Gao, J. J., Liu, Y. J., Mo, Z. W., Wu, F. Y., Hu, Z. J., Peng, Y. M., Zhang, X. Q., Ma, Z. S., Liu, Z. L., Yan, J. Y., Ou, Z. J., Li, Y., & Ou, J. S. (2024). The oxidized phospholipid PGPC impairs endothelial function by promoting endothelial cell ferroptosis via FABP3. Journal of Lipid Research, 65(2), 100499. https://doi.org/10.1016/j.jlr.2024.100499
Vancouver
Chen S, Gao JJ, Liu YJ, Mo ZW, Wu FY, Hu ZJ, et al. The oxidized phospholipid PGPC impairs endothelial function by promoting endothelial cell ferroptosis via FABP3. Journal of Lipid Research. 2024;65(2):100499. doi:10.1016/j.jlr.2024.100499
BibTeX
@article{Chen2024,
author = {Chen, Si and Gao, Jian-Jun and Liu, Yu-Jia and Mo, Zhi-Wei and Wu, Fang-Yuan and Hu, Zuo-Jun and Peng, Yue-Ming and Zhang, Xiao-Qin and Ma, Zhen-Sheng and Liu, Ze-Long and Yan, Jian-Yun and Ou, Zhi-Jun and Li, Yan and Ou, Jing-Song},
title = {The oxidized phospholipid PGPC impairs endothelial function by promoting endothelial cell ferroptosis via FABP3},
journal = {Journal of Lipid Research},
year = {2024},
volume = {65},
number = {2},
pages = {100499},
doi = {10.1016/j.jlr.2024.100499}
}
EUVIMED